The field of cancer research is beginning to embrace a broader perspective that goes beyond genetic and molecular studies, recognizing the significant role ...

Results from the Mariposa study found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced lung ...

New research suggests a genetic mutation previously believed to promote esophageal cancer might actually play a protective ...

Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Cancer in children and adolescents is rare. Nevertheless, malignant diseases are still one of the most common causes of death ...

A new study has shed additional light on why cancer risk seems to change as we grow older, even dropping exponentially after ...

Cancer remission can be partial, complete, or spontaneous. For cancer to be in remission, a decrease in cancer signs for at least a month must be observed. Cancers in remission, however, may come ...

The KRAS gene is responsible for the production of a signaling protein called K-Ras. K-Ras tells cells how to divide, mature, and function. Dysregulation of this protein leads to uncontrolled cell ...